Screener
TG Therapeutics TGTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 1,145,687 | 630,764 |
| Restricted cash | 1,364 | 1,342 |
| Long-term investment securities | 64,368 | 59,136 |
| Right of use assets | 7,085 | 6,278 |
| Deferred tax assets | 343,428 | 348,000 |
| Non-current inventories | 75,486 | 15,689 |
| Other noncurrent assets | 2,211 | 2,044 |
| Total assets | $1,639,629 | $1,063,253 |
Document
FAQ
- What is TG Therapeutics's operating lease ROU assets?
- TG Therapeutics (TGTX) reported operating lease ROU assets of $7.09M in Q2 2026.
- How has TG Therapeutics's operating lease ROU assets changed year-over-year?
- TG Therapeutics's operating lease ROU assets increased by 5.5% year-over-year, from $6.72M to $7.09M.
- What is the long-term trend for TG Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), TG Therapeutics's operating lease ROU assets has grown at a -7.6% compound annual growth rate (CAGR), from $9.31M to $6.28M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about TG Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude